Tiffany Eul Davis Inglis
Chief Medical Officer · SERA PROGNOSTICS, INC.
- 2025
- Oct 13, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Tiffany Eul Davis Inglis files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Zhenya Lindgardt - $291K in SERA purchases and sales in the last 12 months
- Paul Kearney - $131K in SERA purchases and sales in the last 12 months
- Austin Aerts - $66K in SERA purchases and sales in the last 12 months
- Robert Gardner Harrison - $56K in SERA purchases and sales in the last 12 months
- Benjamin Jackson - $38K in SERA purchases and sales in the last 12 months
- John J. Boniface - $34K in SERA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Tiffany Eul Davis Inglis?
Tiffany Eul Davis Inglis is a corporate insider, tracked as Chief Medical Officer of SERA PROGNOSTICS, INC. (SERA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Tiffany Eul Davis Inglis submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Tiffany Eul Davis Inglis been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($18K) across all tracked filings.
